Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISM: BPX-04 Minocycline Gel for Papulopustular Rosacea
NCT03667222Phase 2Unknown
- Sponsor
- BioPharmX
- Start
- Sep 2018
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BPX-04 vehicle topical gel in papulopustular rosacea (2 arms), sponsored by BioPharmX. Primary endpoint: Inflammatory lesion count at 12 weeks. Status: unknown.
02
Drugs
BPX-04 vehicle topical gel
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT03667222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667222.